Is SODIUM HYDROXIDE Safe? — Ingredient Safety Profile · Greenveil
Ingredients SODIUM HYDROXIDE beauty / cleaning / industrial / pharma
SODIUM HYDROXIDE EPA CPDat observed this chemical in 11688 composition records across product categories including Construction and building materials, Raw materials, Home maintenance.
Research docs 0 Claims 0 Sources 179 Function alkalinizing agent • Binder Identifier DTXSID0029634 5
Concern score
5/100 Low concern based on regulatory listings.
How we scored this The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Where it appears Prevalence of SODIUM HYDROXIDE in our catalog (epa_cpdat).
Construction and building materials Raw materials Home maintenance Furniture and furnishings Personal care Laboratory supplies
Typical roles
alkalinizing agent Binder Catalyst chemical peel Cleaning agent
Catalog
Found in these products 542 products Suitability Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
Evidence read The published evidence profile currently shaping this ingredient record.
No evidence profiles are attached to this ingredient yet.
Linked research Primary documents currently linked to this ingredient record.
No linked research documents are attached to this ingredient yet.
Extracted claims Structured claim signals pulled from linked ingredient research.
No extracted claims are attached to this ingredient yet.
Regulatory status Published jurisdiction-level classifications and regulatory designations for this ingredient.
EPA CPDat observed this chemical in 11688 composition records across product categories including Construction and building materials, Raw materials, Home maintenance. EPA CPDat classifies this chemical for functional uses including pH regulating agent, pH balancer, alkalinizing agent.
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.8 %w/w
inactive ingredient database Fragrance
Oxidizing agent
pH balancer
Pantene P
Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH
inactive ingredient database Route: BUCCAL; Dosage form: FILM; Potency: 0.09 mg
inactive ingredient database Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 5 mg
inactive ingredient database Route: BUCCAL; Dosage form: MOUTHWASH; Potency: 2 mg/1ml
inactive ingredient database Route: DENTAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: DENTAL; Dosage form: PASTE; Potency: 0.6 %w/w
inactive ingredient database Route: DENTAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: ENDOTRACHEAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: ENDOTRACHEAL; Dosage form: POWDER, FOR SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: ENDOTRACHEAL; Dosage form: SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: EPIDURAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: EPIDURAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: EPIDURAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: EXTRACORPOREAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INFILTRATION; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTERSTITIAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-AMNIOTIC; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTERIAL; Dosage form: INJECTION; Potency: 176 mg
inactive ingredient database Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTERIAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTICULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: INTRA-ARTICULAR; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH
inactive ingredient database Route: INTRABURSAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRACARDIAC; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRACAUDAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRACAUDAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRACAVITARY; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRADERMAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRADERMAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRADERMAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH
inactive ingredient database Route: INTRADISCAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRALESIONAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: INTRALESIONAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 176 mg
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 7.01 mg
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 0.35 %w/v
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 78 mg
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 27 mg
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: LIQUID; Potency: ADJ PH
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 5.4 mg
inactive ingredient database Route: INTRAOCULAR; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAPERITONEAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRAPERITONEAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAPLEURAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRASPINAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: INTRASYNOVIAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH
inactive ingredient database Route: INTRATHECAL; Dosage form: INJECTION; Potency: 176 mg
inactive ingredient database Route: INTRATHECAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRATHECAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRATHECAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRATUMOR; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRATUMOR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAVASCULAR; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 456 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 136.55 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 78.36 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 78 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: LIQUID; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: POWDER; Potency: ADJ PH
inactive ingredient database Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 2.78 %w/v
inactive ingredient database Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Potency: ADJ PH
inactive ingredient database Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: INTRAVITREAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: IONTOPHORESIS; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: IRRIGATION; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: NASAL; Dosage form: SOLUTION; Potency: 20 mg
inactive ingredient database Route: NASAL; Dosage form: SPRAY; Potency: ADJ PH
inactive ingredient database Route: NASAL; Dosage form: SPRAY, METERED; Potency: ADJ PH
inactive ingredient database Route: OPHTHALMIC; Dosage form: DROPS; Potency: NA
inactive ingredient database Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.02 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 6 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.05 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Potency: 60 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 0.08 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 0.01 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: 0.25 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Potency: 1.5 mg
inactive ingredient database Route: ORAL; Dosage form: CONCENTRATE; Potency: 10 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: ELIXIR; Potency: ADJ PH
inactive ingredient database Route: ORAL; Dosage form: EMULSION; Potency: ADJ PH
inactive ingredient database Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 11 mg
inactive ingredient database Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: ORAL; Dosage form: LIQUID; Potency: 2 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 9 mg
inactive ingredient database Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 9120 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION; Potency: 400 mg
inactive ingredient database Route: ORAL; Dosage form: SYRUP; Potency: 71 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 10 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, COATED; Potency: NA
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 4 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 13 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 8 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1 mg
inactive ingredient database Route: PARENTERAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: PARENTERAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: PARENTERAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: PERIDURAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: PERINEURAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: PERIODONTAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: RECTAL; Dosage form: ENEMA; Potency: 0.44 %v/v
inactive ingredient database Route: RECTAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: RECTAL; Dosage form: SOLUTION; Potency: NA
inactive ingredient database Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, METERED; Potency: ADJ PH
inactive ingredient database Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: ADJ PH
inactive ingredient database Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: 8 %w/v
inactive ingredient database Route: RETROBULBAR; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: SOFT TISSUE; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: SUBARACHNOID; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: SUBCONJUNCTIVAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 31.45 mg
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 1 %w/v
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: ADJ PH
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: NA
inactive ingredient database Route: SUBMUCOSAL; Dosage form: INJECTION; Potency: ADJ PH
inactive ingredient database Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 69 mg
inactive ingredient database Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 6 mg
inactive ingredient database Route: TOPICAL; Dosage form: DISC; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: EMULSION; Potency: 0.2 %w/w
inactive ingredient database Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 20 mg
inactive ingredient database Route: TOPICAL; Dosage form: JELLY; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: LIQUID; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 21 mg
inactive ingredient database Route: TOPICAL; Dosage form: LOTION, AUGMENTED; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: OINTMENT; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: OINTMENT, AUGMENTED; Potency: 0.11 %w/w
inactive ingredient database Route: TOPICAL; Dosage form: SHAMPOO; Maximum daily exposure: 3 mg
inactive ingredient database Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 39 mg
inactive ingredient database Route: TOPICAL; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: SPONGE; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH
inactive ingredient database Route: TOPICAL; Dosage form: SWAB; Potency: 0.01 %w/w
inactive ingredient database Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 0.85 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 350 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: GEL, METERED; Maximum daily exposure: 350 mg
inactive ingredient database Route: URETERAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: URETHRAL; Dosage form: SOLUTION; Potency: ADJ PH
inactive ingredient database Route: VAGINAL; Dosage form: CREAM; Potency: 0.19 %w/w
inactive ingredient database Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 20 mg
listed in openFDA substance openFDA substance registry classifies this ingredient as chemical.
